The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review.
Krieckaert
Charlotte Louise Maria
CL
Department of Rheumatology, Jan van Breemen Institute, Dr Jan van Breemenstraat 2, 1056 AB Amsterdam, The Netherlands. c.krieckaert@janvanbreemen.nl
Bartelds
Geertje Margret
GM
Lems
Willem Frederik
WF
Wolbink
Gerrit Jan
GJ
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000276:immunology*; D004359:Drug Therapy, Combination / Q000379:methods*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D007249:Inflammation / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha